Treace Medical Concepts (TMCI) officer disposes shares for tax or exercise costs

Rhea-AI Filing Summary

TREACE MEDICAL CONCEPTS, INC. reporting person Sean F. Scanlan, Chief Innovation Officer, reported a Form 4 transaction involving 9,814 shares of common stock delivered or withheld for payment of exercise price or tax liability. Following this disposition, he directly holds 679,863 shares of common stock, which includes 463,167 restricted stock units and reflects a transfer of 15,000 shares to a former spouse pursuant to a domestic relations order.

Insider Trade Summary

Net Seller: 9,814 shares

Net Sell 1 txn

Insider Scanlan Sean F.

Role Chief Innovation Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock F1, F2	9,814	$0.00	$0.00

Holdings After Transaction: Common Stock — 679,863 shares (Direct)

Footnotes (2)

1. F1. Includes 463,167 restricted stock units.
2. F2. Reflects the transfer of 15,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order.

Key Figures

Shares delivered/withheld: 9,814 shares Shares held after transaction: 679,863 shares Restricted stock units included: 463,167 units +1 more

4 metrics

Shares delivered/withheld 9,814 shares Common stock used for payment of exercise price or tax liability on 2026-08-09

Shares held after transaction 679,863 shares Direct common stock ownership by Sean F. Scanlan following the disposition

Restricted stock units included 463,167 units RSUs included within the reported 679,863 post-transaction shares

Shares transferred to former spouse 15,000 shares Transfer pursuant to a domestic relations order reflected in post-transaction amounts

Key Terms

restricted stock units, domestic relations order, exercise price or tax liability

3 terms

restricted stock units financial

"Includes 463,167 restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

domestic relations order regulatory

"pursuant to a domestic relations order."

exercise price or tax liability financial

"Payment of exercise price or tax liability by delivering or withholding securities"

FAQ

What insider transaction did TMCI executive Sean F. Scanlan report on this Form 4?

Sean F. Scanlan reported a disposition of 9,814 shares of TREACE MEDICAL CONCEPTS common stock, delivered or withheld to pay the exercise price or tax liability related to equity compensation.

How many TMCI shares does Sean F. Scanlan hold after the reported transaction?

After the transaction, Sean F. Scanlan directly holds 679,863 shares of TREACE MEDICAL CONCEPTS common stock, including 463,167 restricted stock units, as reflected in the post-transaction ownership figure.

What does the 9,814-share disposition by TMCI’s Sean F. Scanlan represent?

The 9,814-share disposition represents shares delivered or withheld for payment of exercise price or tax liability, rather than an open-market sale, according to the transaction’s code F description.

What additional share transfer affecting TMCI’s Sean F. Scanlan is disclosed?

The disclosure notes a transfer of 15,000 shares of common stock to Sean F. Scanlan’s former spouse pursuant to a domestic relations order, which is reflected in the reported post-transaction ownership.

How many restricted stock units does TMCI executive Sean F. Scanlan hold?

Sean F. Scanlan’s post-transaction holdings include 463,167 restricted stock units, which form part of his total 679,863-share direct ownership position in TREACE MEDICAL CONCEPTS common stock.

Was the TMCI Form 4 transaction by Sean F. Scanlan under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan, indicating the reported 9,814-share exercise-price-or-tax-liability disposition is not identified as occurring under such a plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 06:00 PM Accepted by SEC EDGAR 08/12/2026 - 06:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scanlan Sean F.

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FLORIDA 32081

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Innovation Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/09/2026		F		9,814	D	$0	679,863(1)(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 463,167 restricted stock units.

2. Reflects the transfer of 15,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order.

	/s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)